Uribel Tabs Tablet, Coated
Product Images NDC 0178-0745

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Uribel Tabs (NDC 0178-0745). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mission Pharmacal Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

09964346 F420 Bbe0 E063 6394a90a2b9b

URIBEL TABS coated tablet shown in blue, round shape, embossed with 'SAT'. This oral prescription drug contains Methenamine, Benzoic Acid, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate. Labeled by Mission Pharmacal Company, NDC 0178-0745.*

FDA Label Image

Label (Uribel Label)

Uribel Tabs label showing a prescription oral coated tablet containing methenamine 81.6 mg, benzoic acid 9.0 mg, phenyl salicylate 36.2 mg, methylene blue 10.8 mg, and hyoscyamine sulfate 0.12 mg. The label indicates a 100-tablet package distributed by Mission Pharmacal Company. It includes storage instructions and pharmacist and patient notes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.